Discovery Research Articles

31. Preclinical Evaluation Of Antifibrotics In COVID-Induced Fibrosis Model 6/10/2025

    Advancing the development of effective antifibrotic therapies requires urgent investment in clinically relevant, IND-enabling preclinical models to address the growing burden of fibrotic diseases.

32. Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge SCID Mouse Models 6/10/2025

    Advance your RSV therapeutic pipeline with trusted, IND-enabling preclinical services that deliver clinically relevant data through optimized study designs and validated rodent models.

33. Preclinical Evaluation Of RSV Vaccines And Antivirals In BALB/c Mice 6/10/2025

    Accelerate your RSV therapeutic development with clinically relevant preclinical models and expert IND-enabling services that deliver the data needed to advance confidently toward clinical trials.

34. Antibody-Based Drug Discovery At The Speed Of Light 5/23/2025

    Review this end-to-end workflow, including First-to-Human antibody development strategies, the use of the PentaMice® platform for targeted immunization, and the precision of single B cell screening.

35. Specialized Services In Custom Peptide Synthesis (Solution Phase) 5/16/2025

    Our custom peptide synthesis service offers numerous options for synthesis platforms, purity levels, and modifications to meet a variety of research needs.

36. Modelling TPDs Utilizing Computational And Medicinal Chemistry Approaches 5/16/2025

    Through a carefully executed strategy, see how we identified novel degrader molecules with the right physicochemical properties to achieve robust degradation of the target Protein of Interest (POI).

37. A Pre-Clinical Study For Diet-Induced Obesity 3/28/2025

    Here, we look at the importance of using high-fat diet-induced obesity models to evaluate and compare the efficacy of anti-obesity and anti-diabetic treatments like rimonabant and liraglutide.

38. Aragen's Preclinical Oncology Capabilities 3/27/2025

    We provide specialized in vivo pharmacology services, offering customized solutions to support the development of immune-oncology therapies from discovery to commercialization.

39. Propelling Glioblastoma Research: Orthotopic Model Solutions 3/27/2025

    Utilize our luciferase-based orthotopic GBM model to accelerate your research on glioblastoma therapies, offering precise tumor monitoring and non-invasive assessment of treatment efficacy.

40. Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology 3/12/2025

    Scale up your manufacturing of adherent cell cultures used for viral vector-based treatments with the novel technologies needed to facilitate safe, rapid production.